Showing results (111-120 of 588) with videos related to
Sort By:
Pageof 59
Journal of Clinical Medicine|June 2, 2021
Oncological Frontiers in the Treatment of Malignant Pleural MesotheliomaEmanuele Vita, Alessio Stefani, Mariantonietta Di Salvatore, et al.Cancer|September 19, 2002
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimensSergio Ricci, Luca Galli, Aldo Chioni, et al.Clinical Colorectal Cancer|April 16, 2017
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)Fabio Gelsomino, Federica Bertolini, Gabriele Luppi, et al.Breast Cancer Research and Treatment|December 4, 2010
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studiesHenri Roché, Pierfranco Conte, Edith A Perez, et al.Journal of Clinical Pathology|March 6, 2012
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysisMaria Vittoria Dieci, Elena Barbieri, Stefania Bettelli, et al.Future Oncology (London, England)|January 16, 2016
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkersFrancesca Maines, Orazio Caffo, Davide Donner, et al.Experimental and Molecular Pathology|February 27, 2017
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysisAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.Expert Review of Anticancer Therapy|June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysisChiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.Cancers|April 12, 2022
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-AnalysisFederica Galiandro, Salvatore Agnes, Giovanni Moschetta, et al.Anti-Cancer Drugs|September 1, 2007
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyCecilia Nisticò, Emilio Bria, Federica Cuppone, et al.Pageof 59